🔎 Trials Near Me

Akèy › Myelofibroz › Utah › Salt Lake City

Etid klinik pou Myelofibroz nan Salt Lake City, UT

10 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Ap rekriteFaz 1/2
  • Huntsman Cancer Institute, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04176198

Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis

Ap rekriteFaz 1
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07521046

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Ap rekriteFaz 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06661915

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Huntsman Cancer Institute At University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Huntsman Cancer Institute, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

AlloHCT With PegINFa for Myelofibrosis

Ap rekriteFaz 1
  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT05535764

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Ap rekriteFaz 1
  • University of Utah, Salt Lake City
Laj 13 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT04771572

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

Ap rekriteFaz 2
  • Huntsman Cancer Institute, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT05980806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Salt Lake City
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Ap rekriteFaz 3
  • University of Utah, Huntsman Cancer Institute, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2025 · NCT06479135

Etid Myelofibroz nan lòt vil

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.